Piqray 150 mg Alternative – Alpesib (Alpelisib) 150 mg Tablet | Everest Pharmaceuticals

Alpesib 150 mg (Alpelisib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Piqray (Novartis). It belongs to the PI3K-alpha inhibitor class and is used in selected PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer regimens.

Active ingredient: Alpelisib
Strength: 150 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Kisqali 200 mg Alternative – Riboxen (Ribociclib) 200 mg Tablet | Everest Pharmaceuticals

Riboxen 200 mg (Ribociclib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Kisqali (Novartis). It belongs to the CDK4/6 inhibitor class and is used in selected HR-positive, HER2-negative breast cancer regimens.

Active ingredient: Ribociclib
Strength: 200 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Ibrance 125 mg Alternative – Palboxen (Palbociclib) 125 mg Capsule | Everest Pharmaceuticals

Palboxen 125 mg (Palbociclib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Ibrance (Pfizer). It belongs to the CDK4/6 inhibitor class and is used in selected HR-positive, HER2-negative breast cancer regimens.

Active ingredient: Palbociclib
Strength: 125 mg
Form: Capsule
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Femara 2.5 mg Alternative – Femroz (Letrozole) 2.5 mg | Everest Pharmaceuticals

$500.00

Femroz 2.5 mg by Everest Pharmaceuticals Ltd., Bangladesh, contains letrozole 2.5 mg, the same active ingredient and strength as the originator brand Femara 2.5 mg (Novartis). It is a prescription aromatase inhibitor used in the hormonal treatment of certain breast cancers in postmenopausal women.

Originator reference: Femara (Novartis)
Listed alternative brand: Femroz (Everest Pharmaceuticals)
Generic: Letrozole 2.5 mg
Form: Oral tablet
Prescription: Required

Shared ingredients and strength do not establish bioequivalence or automatic interchangeability. Any substitution must be approved by a qualified healthcare professional.